We are live on ! Find out more
LA

LVW Advisors Portfolio holdings

AUM $1.16B
1-Year Est. Return 26.37%
This Fund
S&P 500
This Quarter Est. Return
+7.71%
1 Year Est. Return
+26.37%
3 Year Est. Return
+71.54%
5 Year Est. Return
+76.52%
10 Year Est. Return
+234.09%
AUM
$917M
AUM Growth
+$80.3M
Cap. Flow
+$15.6M
Cap. Flow %
1.7%
Top 10 Hldgs %
47.55%
Holding
344
New
44
Increased
158
Reduced
110
Closed
15

Sector Composition

Rank Sector Weight
1 Technology 10.7%
2 Financials 6.63%
3 Healthcare 3.59%
4 Industrials 3.4%
5 Consumer Discretionary 3.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MKC icon
301
McCormick & Company Non-Voting
MKC
$13.7B
$228K 0.02%
3,010
-309
-9% -$23.1K
NTRA icon
302
Natera
NTRA
$38.3B
$225K 0.02%
1,333
-320
-19% -$49.9K
CVS icon
303
CVS Health
CVS
$133B
$219K 0.02%
3,173
-855
-21% -$56.1K
NKE icon
304
Nike
NKE
$61.9B
$218K 0.02%
3,072
-1,665
-35% -$99.9K
TSN icon
305
Tyson Foods
TSN
$20.4B
$218K 0.02%
3,894
+276
+8% +$15.9K
VRSK icon
306
Verisk Analytics
VRSK
$25.4B
$216K 0.02%
694
-96
-12% -$29.1K
THC icon
307
Tenet Healthcare
THC
$20.5B
$216K 0.02%
+1,225
New +$184K
SNOW icon
308
Snowflake
SNOW
$102B
$215K 0.02%
+962
New +$174K
BXSL icon
309
Blackstone Secured Lending
BXSL
$5.37B
$215K 0.02%
7,000
YUM icon
310
Yum! Brands
YUM
$41.8B
$214K 0.02%
+1,441
New +$210K
WPC icon
311
W.P. Carey
WPC
$16.8B
$212K 0.02%
3,406
NVT icon
312
nVent Electric
NVT
$24.9B
$212K 0.02%
+2,900
New +$178K
DHR icon
313
Danaher
DHR
$137B
$211K 0.02%
+1,068
New +$207K
BMY icon
314
Bristol-Myers Squibb
BMY
$133B
$211K 0.02%
4,553
-291
-6% -$14.3K
PANW icon
315
Palo Alto Networks
PANW
$270B
$208K 0.02%
+1,018
New +$189K
APO icon
316
Apollo Global Management
APO
$72.4B
$208K 0.02%
+1,465
New +$194K
TDG icon
317
TransDigm Group
TDG
$70.2B
$207K 0.02%
+136
New +$191K
VCSH icon
318
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$207K 0.02%
2,600
A icon
319
Agilent Technologies
A
$39.1B
$205K 0.02%
+1,734
New +$192K
VIG icon
320
Vanguard Dividend Appreciation ETF
VIG
$111B
$204K 0.02%
+996
New +$193K
ASND icon
321
Ascendis Pharma A/S
ASND
$16B
$202K 0.02%
+1,168
New +$190K
BBIO icon
322
BridgeBio Pharma
BBIO
$15.7B
$202K 0.02%
+4,667
New +$170K
LIN icon
323
Linde
LIN
$221B
$201K 0.02%
+428
New +$195K
ROIV icon
324
Roivant Sciences
ROIV
$24.5B
$199K 0.02%
+17,616
New +$191K
FWRG icon
325
First Watch Restaurant Group
FWRG
$792M
$173K 0.02%
+10,813
New +$182K

Similar funds

LVW Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, LVW Advisors held 344 positions worth $917M, up 9.6% from $836M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

LVW Advisors's Q2 2025 filing shows 44 new, 158 increased, 110 reduced and 15 closed positions. Its largest new stake was JPMorgan Ultra-Short Income ETF: 13,366 shares worth $677K. The largest sale was iShares Currency Hedged MSCI EAFE ETF, an estimated $63.3M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.2% a quarter earlier, followed by Financials and Healthcare.

  • LVW Advisors's largest Q2 2025 buy was JPMorgan Ultra-Short Income ETF: 13,366 shares worth $677K.
  • LVW Advisors added most to Vanguard FTSE Developed Markets ETF in Q2 2025, an estimated $61.4M increase.
  • LVW Advisors's biggest Q2 2025 reduction was iShares Currency Hedged MSCI EAFE ETF, cutting an estimated $63.3M.
  • LVW Advisors fully exited Charles River Laboratories in Q2 2025, selling an estimated $489K.
  • LVW Advisors's ten largest holdings make up 48% of its $917M portfolio in Q2 2025.
  • LVW Advisors opened 44 new positions and closed 15 in Q2 2025.
  • LVW Advisors's portfolio value rose 9.6% quarter-over-quarter to $917M.

Based on LVW Advisors's 13F filing for Q2 2025, filed 17 Jul 2025.